Clinical Trial Update: Etoposide Plus Benmelstobart Followed by Maintenance Therapy of Benmelstobart Plus Anlotinib in First-line Treatment of Elderly Patients with Extensive Stage Small Cell Lung Cancer: a Single-arm, Prospective Trial

View source ↗

Summary

A single-arm prospective clinical trial in elderly patients with extensive-stage small cell lung cancer evaluating etoposide plus benmelstobart followed by main…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer

Drugs mentioned

• Anlotinib (anlotinib)
• Benmelstobart
• Etoposide (Etoposide)

Snippet

Sponsor: Nanjing First Hospital, Nanjing Medical University | Conditions: Small Cell Lung Cancer Extensive Stage, ELDERLY PEOPLE | Status: NOT_YET_RECRUITING